The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 1×
“Identifying potential measures of potency early in clinical development should evolve from pre-clinical studies (14).”
BackgroundSeddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 2×
“Potency testing results are a required element of product release testing (8,9,13).”
BackgroundDevelopment of a surrogate angiogenic potency assay for clinical-grade stem cell production
Lehman, N., Cutrone, R., Raber, A., Perry, R., van't Hof, W., Deans, R., Ting, A. E., & Woda, J. (2012) · Cytotherapy · doi:10.3109/14653249.2012.688945 · Cited by 76
Self-citation
Cited by
Mesenchymal stem cells: immune evasive, not immune privileged
Ankrum, J. A., Ong, J. F., & Karp, J. M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2816 · Cited by 1,531
Intra-articular treatment options for knee osteoarthritis
Jones, I. A., Togashi, R., Wilson, M. L., Heckmann, N., & Vangsness, C. T. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0123-4 · Cited by 525
MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
Mendicino, M., Bailey, A. M., Wonnacott, K., Puri, R. K., & Bauer, S. R. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.013 · Cited by 497
Manufacturing of primed mesenchymal stromal cells for therapy
Yin, J. Q., Zhu, J., & Ankrum, J. A. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0325-8 · Cited by 343
Quality cell therapy manufacturing by design
Lipsitz, Y. Y., Timmins, N. E., & Zandstra, P. W. (2016) · Nature Biotechnology · doi:10.1038/nbt.3525 · Cited by 311
The Translation of Cell-Based Therapies: Clinical Landscape and Manufacturing Challenges
Heathman, T. R., Nienow, A. W., McCall, M. J., Coopman, K., Kara, B., & Hewitt, C. J. (2015) · Regenerative Medicine · doi:10.2217/rme.14.73 · Cited by 297
Elsallab, M., Bravery, C. A., Kurtz, A., & Abou-El-Enein, M. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.035 · Cited by 59
Self-citationASTM international workshop on standards and measurements for tissue engineering scaffolds
Simon, C. G., Yaszemski, M. J., Ratcliffe, A., Tomlins, P., Luginbuehl, R., & Tesk, J. A. (2015) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.33286 · Cited by 50
Harrison, R. P., Rafiq, Q. A., & Medcalf, N. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.05.003 · Cited by 40
Production and quality testing of multipotent mesenchymal stromal cell therapeutics for clinical use
Bieback, K., Kuçi, S., & Schäfer, R. (2019) · Transfusion · doi:10.1111/trf.15252 · Cited by 24
“Potency assays could also be applied to detect changes in the process and to assess whether changes in manufacturing might affect the product quality.(10) A particular challenge is the identification and provision of internal reference material as quality control that is always available at constant quality, leading t…”
Background
Metadata
- Authors
- Bravery, C. A., Carmen, J., Fong, T., Oprea, W., Hoogendoorn, K. H., Woda, J., Burger, S. R., Rowley, J. A., Bonyhadi, M. L., & Van't Hof, W.
- Venue
- Cytotherapy
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 15
- Issue
- 1
- Pages
- 9-19.e9
- ISSN
- 1465-3249 (ISSN-L)
- OpenAlex
- W1985481249
- Cited by
- 194
- References
- 3
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.